165 related articles for article (PubMed ID: 35092809)
1. Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats.
Fang JL; Vanlandingham MM; Beland FA; Felton RP; Maisha MP; Olson GR; Patton RE; Rosenberg AS; Gamboa da Costa G
Toxicol Lett; 2022 Apr; 359():22-30. PubMed ID: 35092809
[TBL] [Abstract][Full Text] [Related]
2. High molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteins.
Rudmann DG; Alston JT; Hanson JC; Heidel S
Toxicol Pathol; 2013; 41(7):970-83. PubMed ID: 23788571
[TBL] [Abstract][Full Text] [Related]
3. Chronic Toxicology Studies of Basal Insulin Peglispro in Rats and Dogs: A Novel, PEGylated Insulin Lispro Analog with a Prolonged Duration of Action.
Byrd RA; Blackbourne JL; Knadler MP; Schultze AE; Vahle JL
Toxicol Pathol; 2017 Apr; 45(3):402-415. PubMed ID: 28421968
[TBL] [Abstract][Full Text] [Related]
4. Adverse vacuolation in multiple tissues in cynomolgus monkeys following repeat-dose administration of a PEGylated protein.
Fletcher AM; Tellier P; Douville J; Mansell P; Graziano MJ; Mangipudy RS; Brodie TA; Achanzar WE
Toxicol Lett; 2019 Dec; 317():120-129. PubMed ID: 31580884
[TBL] [Abstract][Full Text] [Related]
5. Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG.
Ivens IA; Banczyk D; Gutberlet K; Jackman S; Vauléon S; Frisk AL
Toxicol Pathol; 2019 Jul; 47(5):585-597. PubMed ID: 31132933
[TBL] [Abstract][Full Text] [Related]
6. Final report of the amended safety assessment of PEG-5, -10, -16, -25, -30, and -40 soy sterol.
Int J Toxicol; 2004; 23 Suppl 2():23-47. PubMed ID: 15513823
[TBL] [Abstract][Full Text] [Related]
7. Disposition of Basal Insulin Peglispro Compared with 20-kDa Polyethylene Glycol in Rats Following a Single Intravenous or Subcutaneous Dose.
Knadler MP; Ellis BB; Brown-Augsburger PL; Murphy AT; Martin JA; Wroblewski VJ
Drug Metab Dispos; 2015 Oct; 43(10):1477-83. PubMed ID: 26175543
[TBL] [Abstract][Full Text] [Related]
8. Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins.
Bendele A; Seely J; Richey C; Sennello G; Shopp G
Toxicol Sci; 1998 Apr; 42(2):152-7. PubMed ID: 9579027
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction.
Baumann A; Piel I; Hucke F; Sandmann S; Hetzel T; Schwarz T
Eur J Pharm Sci; 2019 Mar; 130():11-20. PubMed ID: 30654111
[TBL] [Abstract][Full Text] [Related]
10. Effects of polyethylene glycol 400 (PEG 400) following 13 weeks of gavage treatment in Fischer-344 rats.
Hermansky SJ; Neptun DA; Loughran KA; Leung HW
Food Chem Toxicol; 1995 Feb; 33(2):139-49. PubMed ID: 7868000
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
[TBL] [Abstract][Full Text] [Related]
12. Final report on the safety assessment of Triethylene Glycol and PEG-4.
Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481
[TBL] [Abstract][Full Text] [Related]
13. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
Elsadek NE; Emam SE; Abu Lila AS; Shimizu T; Ando H; Ishima Y; Ishida T
Biol Pharm Bull; 2020; 43(9):1393-1397. PubMed ID: 32879214
[TBL] [Abstract][Full Text] [Related]
14. PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.
Chan LJ; Bulitta JB; Ascher DB; Haynes JM; McLeod VM; Porter CJ; Williams CC; Kaminskas LM
Mol Pharm; 2015 Mar; 12(3):794-809. PubMed ID: 25644368
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
16. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products.
Fruijtier-Pölloth C
Toxicology; 2005 Oct; 214(1-2):1-38. PubMed ID: 16011869
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of 10 kDa Linear PEG onto Trastuzumab Fab' Is Sufficient to Significantly Enhance Lymphatic Exposure while Preserving in Vitro Biological Activity.
Chan LJ; Ascher DB; Yadav R; Bulitta JB; Williams CC; Porter CJ; Landersdorfer CB; Kaminskas LM
Mol Pharm; 2016 Apr; 13(4):1229-41. PubMed ID: 26871003
[TBL] [Abstract][Full Text] [Related]
18. Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens.
Corpet DE; Parnaud G; Delverdier M; Peiffer G; Taché S
Cancer Res; 2000 Jun; 60(12):3160-4. PubMed ID: 10866305
[TBL] [Abstract][Full Text] [Related]
19. Systemic toxicity and toxicokinetics of a high dose of polyethylene glycol 400 in dogs following intravenous injection.
Li BQ; Dong X; Fang SH; Gao JY; Yang GQ; Zhao H
Drug Chem Toxicol; 2011 Apr; 34(2):208-12. PubMed ID: 21314471
[TBL] [Abstract][Full Text] [Related]
20. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice.
Yamaoka T; Tabata Y; Ikada Y
J Pharm Sci; 1994 Apr; 83(4):601-6. PubMed ID: 8046623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
